|
| |
Meet the experts in San Diego - Pharmaceutical Profiles to host oral modified
release formulations seminar
10 September 2007
To coincide with the 2007 AAPS Annual Meeting in San Diego, USA, Pharmaceutical
Profiles Ltd (Nottingham, UK) will be hosting a seminar: ‘Successful development
of oral modified release formulations’.
Taking place on 13 November 2007 at the San Diego Marriott & Marina Hotel,
presentations will focus on how understanding oral bioavailability of a drug in
humans, early in clinical development, can help achieve the optimum dosing
regimen – ideally, once-a-day. A line up of high calibre speakers includes Tom
Stephens (Lilly), David Martin (Panacos) and Alex Phipps (Pfizer).
Pharmaceutical Profiles specialises in early clinical drug development, using
innovative technologies and expertise to optimize drug delivery and performance
in the clinic. With more than 16 years’ experience of developing oral dosage
forms to achieve once or twice daily dosing regiments, the company’s human
absorption knowledge has contributed to the development of more than 100 small
molecules, proteins and peptides.
This event is just one in an ongoing programme of workshops and webinars by
Pharmaceutical Profiles. In addition, an extensive library of scientific
publications, posters, presentation and white papers is available from the
Pharmaceutical Profiles website.
For further details on the seminar programme, visit the events section at:
www.pharmprofiles.co.uk
Text ends
For a high resolution image, please email Richard Kent, Kapler Communications
and quote reference: PHA/JOB/008_AAPS.
richard@kapleronline.com
Caption: Pharmaceutical Profiles to host expert seminar in San Diego
About Pharmaceutical Profiles:
- Pharmaceutical Profiles provides drug development support to most of the
top 30 pharmaceutical companies and more than 250 biotechnology companies
worldwide.
- The company specializes in early clinical drug development, with
innovative technologies and expertise to optimize drug delivery and
performance in the clinic.
- World leading expertise in oral drug development has assisted the
development of over 100 small molecules, peptides and protein therapeutics,
including over 30 marketed drugs.
- Unrivalled knowledge and experience in inhaled drug development has
supported the development of the majority of inhaled drug delivery devices and
formulations on the market today.
- Pharmaceutical Profiles has around 100 highly qualified staff with a broad
range of expertise. Facilities include a phase I clinical unit, a GMP facility
for the manufacture of Investigational Medicinal Products (IMPs), and
formulation R&D facilities all under one roof, just south of Nottingham in the
UK.
www.pharmprofiles.com
For further information:
Press information
Richard Kent, Kapler Communications
Tel: +44 (0)1480 479 280 Fax: +44 (0)1480 470343
richard@kapleronline.com
Company contact:
Karen Jones PhD, Vice President, Marketing, Pharmaceutical Profiles Ltd
Tel: +44 (0)115 974 9000
karen.jones@pharmprofiles.co.uk
| |
|
